开发一种通用和六种国家特异性算法以基于ASAS HI评估社会健康效用值
本研究通过欧洲六国随机人群调查,采用最佳-最差选择实验和前置时间权衡实验,开发了一种通用和六种国家特异性算法,将ASAS HI评分转换为脊柱关节炎患者的社会健康效用值。在199例中轴型脊柱关节炎患者中验证显示,通用算法能良好区分高疾病活动度(BASDAI≥4)与低疾病活动度(BASDAI<4)患者(0.18 vs 0.51,p<0.01)。
要点
- 基于ASAS HI开发了1种通用和6种国家特异性算法,用于计算SpA患者社会健康效用值。
- 通用算法在axSpA患者中可区分高、低疾病活动度(BASDAI≥4 vs <4:0.18 vs 0.51)。
- SpA人群效用值范围从最差状态-0.24到最佳健康0.88。
核心结论
- 一种通用和六种国家特异性算法可用于将ASAS HI评分转换为疾病特异性社会健康效用值。
研究设计与样本
- 在六个欧洲国家的随机人群样本中进行调查,共3039名受试者完成最佳-最差选择实验和前置时间权衡实验,并在一组199例中轴型脊柱关节炎患者中测试通用算法。
主要发现
- 3039名受试者平均年龄47岁(SD 15),52%为女性。
- SpA人群健康效用值从最差状态的-0.24(国家范围-0.35至0.03)到最佳健康的0.88(国家范围0.81至0.90)。
- 199例axSpA患者平均效用为0.36(SD 0.30,范围-0.24至0.88)。
- 高疾病活动度(BASDAI≥4)患者效用为0.18(SD 0.24),低疾病活动度(BASDAI<4)患者为0.51(SD 0.27),p<0.01。
关键数值与推荐
- ASAS HI包含17个条目,最佳-最差选择实验每次呈现4个随机条目。
- 基线时间权衡实验分别针对「严重SpA」和「无SpA的最佳健康」进行。
临床怎么用
- 临床中可使用通用或相应国家特异性算法将ASAS HI评分转换为社会健康效用值,用于成本-效用分析等卫生经济学评价。
局限性
- 研究未报告算法在除axSpA外的其他SpA亚型或非欧洲人群中的验证结果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Health utilities represent preference values that persons attach to health states. This study aims to develop one general and six country-specific algorithms to calculate societal preference values for health of patients with spondyloarthritis (SpA), as assessed by the disease-specific Assessment of SpondyloArthritis international Society Health Index (ASAS HI). METHODS: A survey was performed in random population samples from six European countries. In a best-worst choice experiment, subjects were asked to indicate repeatedly which of 4 random aspects of the 17-item ASAS HI was were most and least important. Bayesian analysis provided the relative importance of each of the 17 items. To rescale the relative importance scores on the absolute utility scale between 0 and 1, participants additionally completed two lead time trade-off experiments, one for 'severe SpA' and one for 'best health' without SpA. Six country-specific algorithms and one general algorithm were derived. The general algorithm was tested in 199 patients with axial SpA (axSpA). RESULTS: 3039 subjects, mean age 47 years (SD 15) and 52% female completed the experiments. The population's health utility value for SpA varied between - 0.24 for 'worst' SpA (country range -0.35 to 0.03), and 0.88 for 'best' health (country range 0.81 to 0.90). Among 199 patients with axSpA, the mean utility was 0.36 (SD 0.30, range -0.24 to 0.88) and discriminated well between patients having high (Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) ≥ 4) or low (BASDAI < 4) disease activity (0.18 (SD 0.24) vs 0.51(SD 0.27), p<0.01). CONCLUSION: One general and six country-specific algorithms are available to convert scores from the ASAS HI into disease-specific societal utility values.
引用
- Essers I, Hiligsmann M, Kiltz U, et al. Development of one general and six country-specific algorithms to assess societal health utilities based on ASAS HI. RMD Open. 2019. PMID: 31245046. doi:10.1136/rmdopen-2018-000872
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。